ACM
COGT icon

Aquatic Capital Management’s Cogent Biosciences COGT Stock Holding History

Aquatic Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$516K Buy
+13,328
New +$466K 0.02% 783
2026
Q1 		– Sell
-106,246
Closed -$3.77M – 1447
2025
Q4 		$3.77M Buy
106,246
+48,889
+85% +$1.37M 0.11% 239
2025
Q3 		$824K Buy
+57,357
New +$680K 0.02% 732

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Aquatic Capital Management's COGT Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Cogent Biosciences (COGT) in Q2 2026: 13,328 shares worth $516K. The stake represents 0.02% of the portfolio and ranks #783 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in COGT as recently as Q4 2025.

Aquatic Capital Management first reported a position in COGT in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.77M in Q4 2025. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Aquatic Capital Management held 13,328 shares of Cogent Biosciences worth $516K as of Q2 2026.
  • Cogent Biosciences was a new Aquatic Capital Management position in Q2 2026.
  • Cogent Biosciences made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #783 holding.
  • Aquatic Capital Management first reported a position in Cogent Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Aquatic Capital Management's Cogent Biosciences position peaked at $3.77M in Q4 2025.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.